A Study to Investigate Lung Deposition of Radiolabelled OligoG

NCT01991028 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Cystic Fibrosis

Interventions

DRUG: Radiolabelled OligoG CF-5/20 DPI
DRUG: Radiolabelled OligoG CF-5/20 6% Solution

Sponsor

BDD Pharma Ltd

Collaborators

[object Object]